High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Mat-Su Valley Frontiersman19h
Permanent Fund dividend and one-time bonus confirmed at $1,702, with payments starting Oct. 3
This year’s Permanent Fund dividend, plus a one-time energy rebate bonus, will be a combined $1,702 per recipient, the Alaska ...
Westside Current on MSN22h
Rakuten Medical Presented Research Results of Preclinical Studies for PD-L1-Targeted Photoimmunotherapy at The 83rd Annual Meeting of The Japanese Cancer Association 2024
Presentation of in vitro studies of RM-0256, a novel anti-PD-L1 antibody conjugated to IR700, which comprises a dual mode of photoimmunotherapy: depletion of PD-L1 expressing tumor cells and depletion ...
precisionmedicineonline1d
Oncolytics Biotech Planning for Registration-Directed Pelareorep Trial in Advanced Breast Cancer
If it can secure the funds, Oncolytics will advance the agent into a pivotal study, based on positive data from the Phase I BRACELET-1 trial.
Cambridge University Press5d
Cambridge Prisms: Precision Medicine
This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site https://mc.manuscriptcentral ...